stockrowInterCure Ltd. (INCR) vs Talphera, Inc. (TLPH)
- InterCure Ltd. INCR 3.25 −1.52%
- Talphera, Inc. TLPH 1.02 +0.99%
InterCure Ltd. and Talphera, Inc. are both Drug Manufacturers Specialty & Generic companies. Talphera, Inc. is the larger, with a market value of $52.4M against $39.1M — 1.3× the size. Talphera, Inc. has negative trailing earnings, so its P/E is not meaningful; InterCure Ltd. trades at 6.2×. InterCure Ltd. grew revenue faster over the last twelve months: 16.2% against −73.1%. InterCure Ltd. has the higher net margin (4.88% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, InterCure Ltd. leads on 12 and Talphera, Inc. on 3.
Valuation
Profitability
| Metric | INCR | TLPH | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 32.74% | 100.00% | 53.51% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 4.88% | 0.00% | (2.45%) |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | 0.00% | (143.36%) | (0.80%) |
| Return on assets | 0.00% | (69.60%) | (1.67%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack